Journal article
The drug and vaccine landscape for neglected diseases (2000—11): a systematic assessment
The study concludes that there is a persistent insufficiency in drug and vaccine development for neglected diseases. Nevertheless, these and other data show a slight improvement during the past 12 years in new therapeutics development and registration. However, for many neglected diseases, new therapeutic products urgently need to be developed and delivered to improve control and potentially achieve elimination.
Authors
Languages
- English
Journal
The Lancet Global Health
Volume
6
Type
Journal article
Categories
- Global initiatives
